Organon & Co.
OGN
$7.18
$0.010.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.26% | -0.81% | -6.72% | -0.38% | 4.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.26% | -0.81% | -6.72% | -0.38% | 4.15% |
| Cost of Revenue | 11.23% | 6.29% | -0.30% | 1.90% | 7.68% |
| Gross Profit | -5.85% | -5.86% | -11.18% | -2.08% | 1.76% |
| SG&A Expenses | -1.66% | 3.66% | -2.55% | 21.96% | -21.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.36% | 3.03% | -2.40% | 7.81% | -7.38% |
| Operating Income | -5.13% | -12.95% | -19.32% | -25.38% | 68.10% |
| Income Before Tax | 17.39% | -2.55% | -57.20% | 24.04% | 158.75% |
| Income Tax Expenses | 154.61% | 110.00% | -60.00% | 104.52% | -790.91% |
| Earnings from Continuing Operations | -55.43% | -25.64% | -56.72% | -80.04% | 518.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.43% | -25.64% | -56.72% | -80.04% | 518.97% |
| EBIT | -5.13% | -12.95% | -19.32% | -25.38% | 68.10% |
| EBITDA | 0.65% | -5.97% | -12.73% | -18.28% | 56.66% |
| EPS Basic | -55.86% | -26.40% | -57.08% | -80.20% | 514.46% |
| Normalized Basic EPS | -2.11% | -22.79% | -22.91% | -40.97% | 220.14% |
| EPS Diluted | -55.80% | -25.63% | -57.69% | -80.66% | 508.20% |
| Normalized Diluted EPS | -1.51% | -22.46% | -23.04% | -41.26% | 218.36% |
| Average Basic Shares Outstanding | 0.96% | 1.03% | 0.85% | 0.81% | 0.75% |
| Average Diluted Shares Outstanding | 0.34% | 0.60% | 1.02% | 1.28% | 1.33% |
| Dividend Per Share | -92.86% | -92.86% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.91% | -0.83% | 1.34% | 4.08% | -0.84% |